Lonseth Interventional Pain Centers Offers Spinal Cord Stimulator Trials for Diabetic Peripheral Neuropathy

Lonseth Pain

METAIRIE, La., June 19, 2023 (VSNewsNetwork.com) - Lonseth Interventional Pain Centers, a leading provider of pain management solutions, is proud to introduce Spinal Cord Stimulator (SCS) Trials for individuals suffering from chronic pain conditions, including Diabetic Peripheral Neuropathy. These trials, covered by Medicare, offer a game-changing opportunity for patients who have not found sufficient relief with traditional treatments.

SCS Trials involve the temporary placement of a device that emits low-level electrical signals to the spinal cord or specific nerves, effectively blocking the transmission of pain signals to the brain. This outpatient procedure, conducted under the guidance of experienced professionals, allows patients to experience the potential benefits of SCS without committing to a permanent implant.

The trial period typically lasts for about a week, during which patients and their physicians evaluate the effectiveness of the treatment. Successful trials, often marked by a significant reduction in pain, may lead to the patient becoming a candidate for permanent SCS implantation.

SCS is an advanced therapy that utilizes a device to deliver mild electrical currents to the spinal cord, providing relief for chronic pain. This approach is particularly beneficial when conventional non-surgical treatments have proven ineffective. The device can be programmed to target specific pain areas, making it a viable option for various chronic pain conditions.

During an SCS trial, patients can expect thorough preparation, precise execution of the procedure, and personalized adjustments to ensure optimal pain control. After the procedure, patients take home the trial stimulator for several days to assess its effectiveness in their daily lives.

Candidates for these Medicare-covered SCS trials typically include individuals with chronic pain that hinders their daily activities and has not responded to other treatments. They should not have untreated drug addiction and should have effectively managed any underlying psychiatric conditions. Additionally, patients must be in a suitable health condition to safely undergo the procedure.

Lonseth Interventional Pain Centers is pleased to announce that these groundbreaking SCS trials are covered by Medicare. The dedicated team is ready to support patients throughout each phase, offering a comforting and knowledgeable experience.

Those living with chronic pain do not have to let it dominate their lives. They can take the first step towards finding relief by contacting Lonseth Interventional Pain Centers to schedule a consultation and determine if they qualify for SCS trials. This innovative therapy could unlock a new, less painful chapter in their lives.

Source: Lonseth Interventional Pain Centers via Newswire